Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1273087 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$166,404
-$2,061,226 QoQ
Shares Held
35,863
-95.5% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 98 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. GALT ranks #292 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 468,410 $232,673,299
2 INSM
INSMED Inc
 2,048,005 $218,358,293
3 APGE
Apogee Therapeutics, Inc.
 1,491,404 $197,954,052
4 JAZZ
Jazz Pharmaceuticals plc
 763,880 $184,072,163
5 ONC
BeOne Medicines Ltd.
 543,323 $154,830,755
6 AXSM
Axsome Therapeutics, Inc.
 556,088 $136,113,659
7 BMRN
Biomarin Pharmaceutical Inc
 2,071,816 $118,549,311
8 REGN
Regeneron Pharmaceuticals, Inc.
 165,120 $102,958,924

All Filings in GALT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $166,404 35,863
2026-03-31 $2,227,630 798,434
2025-12-31 $979,713 235,508
2025-09-30 $468,189 110,422
2025-06-30 $304,954 144,528
2024-12-31 $13,039 10,108
2024-09-30 $100,023 36,372
2024-06-30 $120,491 53,315
2024-03-31 $59,943 25,081
2023-12-31 $46,066 27,751
2023-09-30 $197,084 102,648
2023-06-30 $199,373 138,454
2023-03-31 $276,723 131,773
2022-12-31 $294,823 260,906
2022-09-30 $394,373 241,947
2022-06-30 $338,665 258,523
2022-03-31 $544,104 337,953
2021-12-31 $839,594 405,601
2021-09-30 $1,359,303 350,336
2021-06-30 $1,819,808 568,690